Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
Notwendige Cookies
Diese Cookies sind für das Funktionieren des Logins und die Speicherung der Cookie-Einstellungen erforderlich und können deshalb nicht deaktiviert werden.
Benzinga publiziert News und Analysen schwerpunktmäßig zum amerikanischen Aktienmarkt. Neben frei zugänglichen Artikeln auf Benzinga.com bietet das Unternehmen gegen Bezahlung exklusive Berichte, Features und Audio- Mitteilungen an.
SpaceX IPO buzz is pushing ETFs into private-market exposure. Here's how funds are positioning — and what investors should watch.
Importance Rank:
1
read more...
FuboTV shares are dropping on Wednesday. The stock has continued to drift downward following its first‑quarter 2026 earnings release.
Importance Rank:
1
read more...
GlobalFoundries (GFS) tops Q4 expectations and announces a $500 million buyback. CEO Tim Breen explains the company's pivot to "Physical AI"—the tech powering tomorrow's autonomous cars and robots—and a path to $1 billion in silicon photonics revenue.
Importance Rank:
1
read more...
Coca-Cola shares rose after the company beat Q4 profit estimates and reaffirmed its 2026 growth outlook, with analysts citing improving volumes and margin expansion.
Latest Ratings for KO
DateFirmActionFromTo Feb 2022Deutsche BankMaintainsHold Feb 2022Morgan StanleyMaintainsOverweight Feb 2022Morgan StanleyMaintainsOverweight
View More Analyst Ratings for KO
View the Latest Analyst Ratings
Importance Rank:
1
read more...
After three straight rebound sessions, the software selloff resumed Wednesday, with the iShares Tech-Expanded Software Sector ETF (NYSE:IGV)
Importance Rank:
1...
NIH stops rivaroxaban arm in CAPTIVA stroke trial after safety events and futility signal; study continues with other treatment groups.
Importance Rank:
1
read more...
CVS reaffirmed fiscal 2026 guidance, and expects strong growth. Analyst views this as positive and maintain a Buy rating.
Latest Ratings for CVS
DateFirmActionFromTo Feb 2022Raymond JamesDowngradesStrong BuyOutperform Dec 2021Tigress FinancialMaintainsBuy Dec 2021MizuhoMaintainsBuy
View More Analyst Ratings for CVS
View the Latest Analyst Ratings
Importance Rank:
1
read more...
Tower Semiconductor (TSEM) beat Q4 estimates with strong revenue and earnings, driven by surging margins and demand for silicon photonics.
Importance Rank:
1
read more...